#1Investor Presentation Mike Lobinsky, CEO Valérie Worrall, CFO FY20 & 1Q21 EOS imaging CONNECTING IMAGING TO CARE BOOOD 6000 00 0000 000000 0000000#2EOS imaging Disclaimer This document has been prepared by EOS imaging (the "Company") and is provided for information purposes only. The information and opinions contained in this document speak only as of the date of this document and may be updated, supplemented, revised, verified or amended, and such information may be subject to significant changes. EOS imaging is not under any obligation to update the information contained herein and any opinion expressed in this document is subject to change without prior notice. The information contained in this document has not been independently verified. No representation, warranty or undertaking, express or implied, is made as to the accuracy, completeness or appropriateness of the information and opinions contained in this document. The Company, its subsidiary, its advisors and representatives accept no responsibility for and shall not be held liable for any loss or damage that may arise from the use of this document or the information or opinions contained herein. This document contains information on the Company's markets and competitive position, and more specifically, on the size of its markets. This information has been drawn from various sources or from the Company's own estimates. Investors should not base their investment decision on this information. This document contains certain forward-looking statements. These statements are not guarantees of the Company's future performance. These forward looking statements relate to the Company's future prospects, developments and marketing strategy and are based on analyses of earnings forecasts and estimates of amounts not yet determinable. Forward-looking statements are subject to a variety of risks and uncertainties as they relate to future events and are dependent on circumstances that may or may not materialize in the future. EOS imaging draws your attention to the fact that as forward-looking statements cannot under any circumstance be construed as a guarantee of the Company's future performance and that the Company's actual financial position, results and cash flow, as well as the trends in the sector in which the Company operate may differ materially from those proposed or reflected in the forward-looking statements contained in this document. Furthermore, even if EOS imaging' financial position, results, cashflows and developments in the sector in which the Company operates were to conform to the forward-looking statements contained in this document, such results or developments cannot be construed as a reliable indication of the Company's future results or developments. The Company does not undertake any obligation to update or to confirm projections or estimates made by analysts or to make public any correction to any prospective information in order to reflect an event or circumstance that may occur after the date of this presentation. A description of those events that may have a material adverse effect on the business, financial position or results of EOS imaging, or on its ability to meet its targets, appears in the "Risk Factors" section of EOS imaging Financial Annual Report available on the Company's website. Certain figures and numbers appearing in this document have been rounded. Consequently, the total amounts and percentages appearing in the tables are therefore not necessarily equal to the sum of the individually rounded figures, amounts or percentages. This document does not constitute or form part of an offer to sell or to purchase securities or the solicitation of an offer to purchase securities in the United States of America or in any other jurisdiction. The securities mentioned in this presentation have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or under any other legislation of any jurisdiction in the United States of America and may not be offered or sold in the United States absent registration or an applicable exemption from registration under the Securities Act. CONNECTING IMAGING TO CARE April 2021 2#3E3!!!! C E! EOS imaging EOS imaging: a leader in orthopedic medical imaging and software solutions Unique, innovative, low dose 2D/3D full body imaging and software solutions bridging the gap between imaging and orthopedic surgery EOSedge: a disruptive imaging system with regulatory approvals in the U.S., Europe, Canada and Australia EOS system, the first-generation system recognized worldwide with clearance to market in 51 countries incl. U.S. (FDA), Japan, China, and the European Union (CE), with over 400 units installed worldwide A product portfolio targeting a ~€2 billion per year addressable market Strategic partnerships in selected countries and direct commercial presence with offices in France (HQ), U.S., Canada, Germany, and Singapore > 160 employees, including an R&D team of 45 engineers CONNECTING IMAGING TO CARE April 2021 3#4EOS imaging Experienced Complimentary Management Team Combined 120+ Years Medical Technology Experience Mike Lobinsky - Chief Executive Officer • Over 20 years experience in Medical Device • Held senior management positions at Smith and Nephew, Brainlab, Blue Belt Technologies, Stryker Corp Joined the company in 2017 Appointed CEO Jan 2019 Carl Denys - VP Global Marketing ° • ° Over 25 years of global medical industry experience in upstream/downstream marketing, business development, and sales operations. Held senior management positions at IMRIS, St. Jude Medical, and Boston Scientific Joined EOS imaging in 2020 Eric Maulave - Chief Operating Officer Over 25 years of experience and began his career as business engineer for the IT and Multimedia sectors within the Philips Group. Held various international positions as Sales and Marketing Director within the Philips Group. • Joined EOS imaging in 2012 Pascal Désauté - Chief Technology Officer Over 18 years of experience in R&D and engineering in the healthcare market 5 years of experience in R&D in mutli-energy X-ray cargo imaging Contributed to the development of the gaseous detector of EOS, and to the overall device EOS Joined EOS imaging in 1997 Valerie Worrall - Chief Financial Officer Over 20 years' experience in Finance in the Healthcare industry She had a long tenure with Novartis and GSK and was also CFO of Balt, a French Medical device company Joined EOS imaging in November 2018 CONNECTING IMAGING TO CARE April 2021 4#5EOS imaging Differentiated orthopedic imaging platform Addressing Weaknesses of Conventional Imaging Current orthopedic imaging modalities Bone Imaging Soft tissue imaging EOS OFFERING X-RAY: CR/DR CT SCANNER MRI ULTRASOUND Low dose 3D imaging Full-body (no stitching) Weight-bearing *Only available in non-functional positions EOS X-Ray Continuous, full-body imaging Imprecise, stitched imaging CONNECTING IMAGING TO CARE April 2021 5#6EOS imaging EOS Orthopedic Solutions Expansion Beyond Radiology System & Creation of 2 Focused Divisions EOS EOS Imaging Solutions EOS edge EOS edge edge EOS Advanced Orthopedic Solutions — 3D Modeling 3D Surgical planning Surgery On-site & 3DServices 3D modeling of musculoskeletal system EOSapps 3D surgical planning & patient engagement EOSlink™ Integration of EOSapps surgical planning into the OR CONNECTING IMAGING TO CARE April 2021 6#7Clinical innovation through cutting-edge technology EOS 13935 EOS edge adge EOS EOS imaging 2008 Stereo-radiographic full body weight-bearing acquisition Low dose imaging 3D modeling with accurate measurements *ALARA - As Low As Reasonably Achievable 2019 First general X-ray system with photon-counting detectors Unique image resolution to support diagnostic capabilities Optimized dose modulation with Flex Dose' TM Open design and short exam time (<20 sec) Designed to extend diagnostic imaging utilization CONNECTING IMAGING TO CARE April 2021 7#8Installed base as of December 31st, 2020 Over 400 Systems Installed Worldwide, of which over 150 in NAM U.S: > 130 EOS installed NAM SHSS Advocate NYU Health Care CH MAYO CLINIC Rady Childrens Hospit San Dispo Children's Hospital of Philadelphia NewYork-Presbyterian The University Hospital of Columbia and Cornell MASSACHUSETTS MGH GENERAL HOSPITAL 1511 Texas Health Presbyterian Hospital BARNES JEWISH Hospital BIC Health are Northwestern University Shriners Hospitals Nicklaus Children's Hospital for Children' EOS imaging 00000 000 .. 20000 39% 000 000 00 0000 00000000000000 0000000 00 • 00 000 Lat. Am 1% 000 0000 000000000 0000000 000 e • 60000 00000 EMEA 44% 00000000 100 00 France: > 90 EOS installed 70% in Private settings Germany: > 15 EOS installed 50% in Private settings Erasmus MC Intersity Medical Car ASSISTANCE PUBLIQUE Almaviva CLINIQUE ARAGO த HÔPITAUX DE PARIS 00 Necker مستشفى كينغز كوليدج لندن King's College Hospital London NHS 香港中文大學(深圳) St George's University Hospitals The Chinese Chaversity offline one. See NHS Foundation Trust schulthess klinik 00001 0000 CHARITÉ HUG Hôpitaux Universitaires Genève 香港大學 THE UNIVERSITY OF HONG KONG The Royal Children's Hospital Melbourne MACQUARIE UNIVERSITY Hospital NUH SAMSUNG SAMSUNG MEDICAL CENTER 国家公務員共済組合連合会 名城病院 (0 SONIC HEALTHCARE CONNECTING IMAGING TO CARE 000000000 Asia-Pac. $16% 00 Australia: > 20 EOS installed 80% in Private setiings 0000 April 2021 8#9Global top hospital penetration EOS in 7 of the top 10 best hospitals in the world* EOS imaging 70% UUU + MAYO CLINIC T 1 Mayo Clinic 2 Cleveland Clinic сэсэхэ TOP # 10 WORLD BEST HOSPITAL Cleveland Clinic JOHNS HOPKINS MEDICINE THE JOHNS HOPKING HOSPITAL CHARITÉ UNIVERSITATSMEDVIN MGH 1811 CHUV 3 Singapore General Hospital (Bukit Merah) 4 The Johns Hopkins Hospital (Baltimore) 5 Charité (Berlin) 6 Massachusetts General Hospital (Boston) 7 Toronto General Hospital 8 University of Tokyo Hospital 9 Lausanne (Switzerland) University Hospital 10 Sheba Medical Center (Tel Aviv, Israel) *https://www.newsweek.com/2019/04/05/10-best-hospitals-world-1368512.html CONNECTING IMAGING TO CARE April 2021 9#10EOS imaging EOS solutions in the best hospitals US News and Word Report 2020-21 BEST HOSPITALS & WORLD REPORT US.News 2020-21 100% 90% 80% of the top 10 Best Pediatric Hospitals "Honor Roll❞ of the top 10 Best Pediatric Hospitals for Orthopedics of the top 10 Best Hospitals for Orthopedics 90% of the top 10 Best Hospitals for Neurosurgery CONNECTING IMAGING TO CARE April 2021 10#11Financials - 2020 Annual Results EOS CONNECTING IMAGING TO CARE imaging 11#12EOS imaging 2020 Financial Highlights €23.8m €12.9m €24.4m 2020 revenues 2020 €11.2m recurring OpEx Net Loss (+19%) revenues Double digit growth from all Regions +11% VS. 2019 thanks to the continued growth in maintenance activity (+15%) -13% VS. 2019 as a result of a sharp decrease in Sales & Marketing expenses (-34%) Decreased by 39% VS. 2019 CONNECTING IMAGING TO CARE €9.7m Cash Position Increased vs. €8.2m at December 31,2019 April 2021 12#132020 Equipment Orders > €18.3 million of equipment orders in 2020 (40 orders booked including 20 EOS edge) vs. 56 orders in 2019 > €8.1 million of equipment orders in Q4 2020 (18 orders booked) vs. 12 orders in Q4 2019. > EOSedge represented 85% of the orders in the countries where it is commercialized EOS imaging 2020 Equipment Orders by Region EUR million EOS imaging quarterly Equipment Orders EUR million EOS imaging 9,2 5,7 9,8 EMEA NAM 6,0 6,6 5,1 2019 2020 24,0 18,3 6,3 6,6 3,0 8,1 5,8 5,3 5,4 1,9 24,0 APAC GLOBAL Q1 Q2 Q4 Total 2019 2020 CONNECTING IMAGING TO CARE 18,3 April 2021 13#14Change in the commercial cycle in 2019 ⚫ Shift by 3 to 15 months of the equipment delivery to the customer ⚫ The order taking and installation activities remained unchanged ⚫ The cash stream remained unchanged: deposit at order and final payment at acceptance ⚫ Decreased working capital thanks to reduced time from equipment production to installation One-time transition impact on equipment revenue, as equipment billing (at delivery) are delayed until customer site readiness Up to December 2018 Sales Agreement Since January 2019 Sales Agreement Cash cycle unchanged EOS Downpayment Equipment Delivery Site Preparation by the Customer [3 to 15 months] Installation & Acceptance Site Preparation by the Customer [3 to 15 months] Equipement Delivery CONNECTING IMAGING TO CARE Installation & Acceptance Final Payment imaging April 2021 14#15#o EOS Dec 2018 Order Book as of December 31, 2020 > 18 equipment orders in Q4 2020, for a total of €8.1 million, 40 orders in 2020 for a total of €18.3m > €15.2m gross equipment revenues from the billing of 34 equipment of which 15 in Q4 2020 > Order book up by €1.3 million during Q4 to reach €17.4 million at December 31, 2020, as new orders exceed deliveries EOS imaging Order Book Variation - EUR million New orders Q1 2019 EOS imaging Quarterly Equipment new Orders Quarterly Revenues recorded from Equipment delivered Equipment Order Book Value as of end of the quarter #15 EOS Sales Q1 2019 0,1 #12 EOS* #14 EOS 3,5 #33 EOS 5.4 5,3 #32 EOS #15 EOS 5.8 #28 EOS #2 EOS #9 EOS #13 EOS #6 EOS 6.6 #2 EOS #15 EOS Book Value March 2019 6,2 New Orders Q2 2019 Sales Q2 2019 12,1 Book Value June 2019 New Orders Q3 2019 Sales Q3 2019 Book Value Sept. 2019 14,4 New Orders Q4 2019 Sales Q4 2019 Book Value Dec. 2019 14,4 New Orders Q1 2020 Sales Q1 2020 Book Value March 2020 #4 EOS #36 EOS 16,7 New Orders Q2 2020 Sales Q2 2020 #18 EOS #12 EOS 6,6 8,1 #38 EOS #35 EOS 2,9 5,0 #30 EOS #15 EOS #7 EOS #10 EOS Book Value June 2020 CONNECTING IMAGING TO CARE 13,6 New Orders Q3 2020 * As a reminder, orders in Q4 2019, expected to exceed 18 units (Q4 2018 performance), have been postponed by customers with the arrival of the new EOSedge offer on 1 December 2019. 17,4 16,0 Sales Q3 2020 Book Value Sept 2020 New Orders Q4 2020 Sales Q4 2020 Book Value Dec. 2020 April 2021 15#16EOS imaging 2020 Detailed Revenue Breakdown Revenues by product lines Change Unaudited/Including forex impact / €m/ 2020 2019 Change constant As of Dec. 31 2020 rate Equipment 10.9 8.5 +29% +29% Maintenance contracts 12.0 10.5 +15% +16% Consumables and associated services 0.9 1.2 -26% -26% TOTAL REVENUES 23.8 20.1 +19% +19% Revenues by region Change Geographic Unaudited/Including forex impact / €m/ 2020 2019 Change constant split As of Dec. 31 2020 rate EMEA 11.0 9.9 +11% +11% 46% APAC 5.3 3.8 +39% +39% 22% NAM 7.4 6.3 +17% +20% 31% LATAM 0.6 0.0 +77% +77% 0% TOTAL REVENUES 23.8 20.1 +19% +19% 100% CONNECTING IMAGING TO CARE April 2021 16#172020 Income statement Lower operating expenses and reduction in operating loss 2020 Income Statement / € million Unaudited As of December 31 Sales Other income 2020 2019 23.8 20.1 2.2 2.1 TOTAL REVENUES Direct cost of sales GROSS MARGIN 26.0 22.2 (11.2) (11.0) 12.6 9.1 as a % of revenue 52.9% 45.4% excluding exceptional items as % of revenues 54.3% 49.8% Total operating expenses (24.4) (27.9) Operating income/(loss) Net financial income/(expense) Net income/(loss) EOS imaging (9.6) (16.7) (1.6) (1.7) (11.2) (18.4) CONNECTING IMAGING TO CARE Total revenues of €23.8 million generated in 2020 (+19%) vs. 2019, which had been impacted by the business model transition Improvement in Gross margin from 49.8% to 54.4% An OPEX decrease by 13% vs. 2019 Significant reduction in net loss by 39% April 2021 17#18EOS imaging 2020 Operating Expenses Operating expenses totaled €24.4 million in 2020, down 13% compared to 2019 Operating Expenses / € million Unaudited 2020 2019 As of December 31 Indirect cost of production and services 4.6 4.4 Research & Development 5.6 4.8 Sales, Marketing and Clinical Regulatory expenses Administrative costs Share-based payments TOTAL OPERATING EXPENSES 7.4 11.2 0.8 0.9 6.0 5.9 0.0 0.7 24.4 27.9 CONNECTING IMAGING TO CARE Sales & Marketing expenses (-34%), following in particular the cancellation of trade shows and the reduction in travel expenses due to the pandemic and its restrictions April 2021 18#19Change of Commercial Cycle continues to fuel Working Capital Reduction EOS imaging Balance Sheet main elements change from December 2018 to December 2020 EUR million 32,7 17,7 9,8 Dec. 2018 Dec., 2019 ■Dec., 2020 34,4 27,2 19,8 13,5 13,4 8,8 (4,0) (3,4) (7,1) Receivables Inventories Payables Net Working Capital (NWC) Net Working Capital Variation from December 2019 to December 2020 EUR million 27,2 (7,9) (0,1) 0,5 19,8 NWC Receivables Inventories Payables as of Dec. 2019 NWC as of Dec. 2020 Continued reduction of Receivables Stable inventories Significant improvement in working capital CONNECTING IMAGING TO CARE April 2021 19#20EOS imaging 2020 Balance Sheet Balance Sheet/ € million Unaudited 2020 2019 Goodwill Intangible Assets 5.1 5.1 8.5 8.5 Lease Right-of-Use 3.7 4.4 Tangible Assets 1.5 2.1 Total non-current Assets 19.0 20.3 Inventories 13.4 13.5 Total Receivables 9.8 17.7 Strong reduction of Receivables, as expected, thanks to the new commercial cycle Other Current Assets 3.2 5.2 Cash 9.7 8.2 Total Current Assets 36.1 44.6 Total Assets 55.1 64.9 Total Equity 0.4 12.1 Total non-current Liabilities 28.4 29.7 Trade payables 3.4 4.0 Other liabilities and adj. Accounts 19.8 15.6 Total current Liabilities 26.3 23.1 Total Liabilities 55.1 64.9 CONNECTING IMAGING TO CARE April 2021 20#21EOS imaging 2020 Cash Flow Statement Cash position of €9.7m at December 31, 2020 compared with €8.2 million at December 31, 2019 Positive Cash flow from operating activities: +€4.7m Cash Flow Statement / € million Unaudited 2020 2019 Net Income (11.2) (18.4) Restatement of non-cash items 2.8 2.9 Restatement of financial items Working Capital variation (0.2) (0.0) 13.3 8.0 Cash Flow from operating activities 4.7 (7.6) Cash Flow from investing activities (2.2) (2.7) Cash Flow from financing activities (0.8) (1.3) Net Cash Flows 1.7 (11.6) Cash Position at end of the period 9.7 8.2 CONNECTING IMAGING TO CARE April 2021 21#22Q1 2021 sales EOS CONNECTING IMAGING TO CARE imaging 22#23EOS imaging > Q1 2021 Equipment Orders €4.7 million of equipment orders, (11 systems ordered) vs. €3.0 million in Q1 2020 (6 systems ordered) EOS imaging Q1 Equipment Orders by Region EUR million 0,6 1,1 42 1,4 1,3 1,2 EMEA APAC Q1 2020 ■Q1 2021 3,0 2,2 +55% 4,7 NAM GLOBAL CONNECTING IMAGING TO CARE April 2021 23#24EOS imaging EOS imaging | Q1 2021 Detailed Revenues Breakdown > €5.59m of revenues generated over Q1 2021, a sharp increase (+48%) vs. Q1 2020 ⚫ Of which €2.34m of equipment sales and €3.26m of recurring revenues › Commercial performance* at €7.9m, up 31% compared to Q1 2020 Revenues by product lines Non-audited/Including forex impact / € million | As of March 31 Equipment Maintenance contracts Consumables and services Q1 2021 Q1 2020 2.3 0.7 3.1 2.7 0.2 0.3 TOTAL REVENUES 5.6 3.8 Revenues by geographies Q1 Q1 Non-audited/Including forex impact / € million | As of March 31 2021 2020 EMEA APAC NAM 2.4 1.7 0.3 0.6 2.9 1.4 TOTAL REVENUES 5.6 3.8 *Commercial performance: sum of recurring revenues and equipment orders generated over a period CONNECTING IMAGING TO CARE April 2021 24#25#o EOS Dec 2018 New orders Q1 2019 EOS imaging Order Book as of March 31, 2021 11 equipment orders in Q1 2021, for a total of €4.7 million €2.3m gross equipment revenues from the billing of 4 equipment › Order book up by €2.3 million during Q1 to reach €19.7 million at March 31, 2021, as new orders exceed deliveries EOS imaging Order Book Variation - EUR million Quarterly Equipment new Orders Quarterly Revenues recorded from Equipment delivered Equipment Order Book Value as of end of the quarter #18 EOS #15 EOS 0,1 #15 EOS Sales Q1 2019 Book Value March 2019 6,2 New Orders Q2 2019 6.6 #2 EOS 12,1 #12 EOS* #11 EOS #4 EOS #14 EOS #12 EOS 6,6 #45 EOS 2,3 #36 EOS #38 EOS 4.7 3.5 #33 EOS 5,3 #32 EOS #15 EOS 0,7 #2 EOS 5,0 #30 EOS #28 EOS 2,9 #35 EOS #7 EOS #15 EOS #4 EOS #9 EOS #13 EOS #6 EOS #10 EOS Sales Q2 2019 Book Value June 2019 New Orders Q3 2019 Sales Q3 2019 Book Value Sept. 2019 14,4 New Orders Q4 2019 Sales Q4 2019 Book Value Dec. 2019 14,4 New Orders Q1 2020 Sales Q1 2020 Book Value March 2020 16,7 New Orders Q2 2020 Sales Q2 2020 Book Value June 2020 19,7 17,4 16,0 13,6 New Orders Q3 2020 CONNECTING IMAGING TO CARE * As a reminder, orders in Q4 2019, expected to exceed 18 units (Q4 2018 performance), have been postponed by customers with the arrival of the new EOSedge offer on 1 December 2019. Sales Q3 2020 Book Value Sept 2020 New Orders Q4 2020 Sales Q4 2020 Book Value Dec. 2020 New Orders Q1 2021 Sales Q1 2021 Book Value March. 2021 April 2021 25#26Contact Phone: +33 (0)1 55 25 60 60 Email: [email protected] www.eos-imaging.com EOS imaging CONNECTING IMAGING TO CARE BOOOD 6000 00 0000 000000 0000000